Literature DB >> 3492968

Favourable prognostic features in histiocytosis X: bone involvement and absence of skin disease.

V Broadbent.   

Abstract

The records of 70 patients presenting to this hospital since 1961 with histiocytosis X confirmed by biopsy examination have been reviewed. The patients were subdivided into three groups: group A, those under 2 years of age at diagnosis; group B, those between 2 and 5 years; and group C, those over 5 years. All eight patients who died (11% overall mortality) were under 2 years of age at diagnosis. Involvement of lung, liver, and bone marrow were confirmed as poor prognostic features. The presence of bone disease and absence of skin rash were identified as favourable features.

Entities:  

Mesh:

Year:  1986        PMID: 3492968      PMCID: PMC1778216          DOI: 10.1136/adc.61.12.1219

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  6 in total

1.  Histiocytosis x--an analysis of prognostic factors.

Authors:  E Lahey
Journal:  J Pediatr       Date:  1975-08       Impact factor: 4.406

2.  The course and prognosis of reticuloendotheliosis (eosinophilic granuloma, Schüller-Christian disease and Letterer-Siwe disease); a study of forty cases.

Authors:  M E AVERY; J G MCAFEE; H G GUILD
Journal:  Am J Med       Date:  1957-04       Impact factor: 4.965

3.  Histiocytosis X--current controversies.

Authors:  V Broadbent; J Pritchard
Journal:  Arch Dis Child       Date:  1985-07       Impact factor: 3.791

4.  A staging system for histiocytosis X: a Southwest Oncology Group Study.

Authors:  D M Komp; J Herson; K A Starling; T J Vietti; E Hvizdala
Journal:  Cancer       Date:  1981-02-15       Impact factor: 6.860

5.  Quality of survival in histiocytosis X: a Southwest Oncology Group study.

Authors:  D M Komp; A El Mahdi; K A Starling; J Easley; T J Vietti; D H Berry; S L George
Journal:  Med Pediatr Oncol       Date:  1980

Review 6.  The histiocytic disorders: a pathophysiologic analysis.

Authors:  J E Groopman; D W Golde
Journal:  Ann Intern Med       Date:  1981-01       Impact factor: 25.391

  6 in total
  2 in total

1.  A multicentre retrospective survey of Langerhans' cell histiocytosis: 348 cases observed between 1983 and 1993. The French Langerhans' Cell Histiocytosis Study Group.

Authors: 
Journal:  Arch Dis Child       Date:  1996-07       Impact factor: 3.791

2.  BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy.

Authors:  Sébastien Héritier; Jean-François Emile; Mohamed-Aziz Barkaoui; Caroline Thomas; Sylvie Fraitag; Sabah Boudjemaa; Florence Renaud; Anne Moreau; Michel Peuchmaur; Catherine Chassagne-Clément; Frédérique Dijoud; Valérie Rigau; Despina Moshous; Anne Lambilliotte; Françoise Mazingue; Kamila Kebaili; Jean Miron; Eric Jeziorski; Geneviève Plat; Nathalie Aladjidi; Alina Ferster; Hélène Pacquement; Claire Galambrun; Laurence Brugières; Guy Leverger; Ludovic Mansuy; Catherine Paillard; Anne Deville; Corinne Armari-Alla; Anne Lutun; Marion Gillibert-Yvert; Jean-Louis Stephan; Fleur Cohen-Aubart; Julien Haroche; Isabelle Pellier; Frédéric Millot; Brigitte Lescoeur; Virginie Gandemer; Christine Bodemer; Roger Lacave; Zofia Hélias-Rodzewicz; Valérie Taly; Frédéric Geissmann; Jean Donadieu
Journal:  J Clin Oncol       Date:  2016-07-05       Impact factor: 44.544

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.